These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5017240)

  • 1. Hyporeninemic hypertension.
    Crane MG; Harris JJ; Johns VJ
    Am J Med; 1972 Apr; 52(4):457-66. PubMed ID: 5017240
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of hyperaldosteronism in the pathogenesis of arterial hypertension in pheochromocytoma].
    Gerasimenko PP
    Kardiologiia; 1973 May; 13(5):84-90. PubMed ID: 4720573
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
    Ferriss JB; Brown JJ; Fraser R; Kay AW; Neville AM; O'Muircheartaigh IG; Robertson JI; Symington T; Lever AF
    Lancet; 1970 Nov; 2(7681):995-1000. PubMed ID: 4098088
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
    Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
    Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of spironolactone in hypertensive patients.
    Crane MG; Harris JJ
    Am J Med Sci; 1970 Dec; 260(6):311-30. PubMed ID: 5511395
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 11. Renin and aldosterone in essential hypertension.
    Kotchen TA; Mulrow RJ; Morrow LB; Shutkin PM; Marieb N
    Clin Sci; 1971 Oct; 41(4):321-31. PubMed ID: 5097475
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.
    Ferriss JB; Brown JJ; Fraser R; Haywood E; Davies DL; Kay AW; Lever AF; Robertson JI; Owen K; Peart WS
    Br Med J; 1975 Jan; 1(5950):135-8. PubMed ID: 234268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-dependent essential and steroid hypertension.
    Dustan HP; Bravo EL; Tarazi RC
    Am J Cardiol; 1973 May; 31(5):606-15. PubMed ID: 4698131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on the renin-angiotensin-aldosterone system. Effects of sodium restriction and postural changes on plasma renin activity and fluctuation in urinary aldosterone].
    Kubota K
    Jpn Circ J; 1969 Mar; 33(3):323-32. PubMed ID: 4307397
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
    Mantero F; Armanini D; Urbani S
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():219s-24. PubMed ID: 4522169
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension, adrenal abnormalities, and alterations in plasma renin activity.
    Gunnells JC; McGuffin WL; Robinson RR; Grim CE; Wells S; Silver D; Glenn JF
    Ann Intern Med; 1970 Dec; 73(6):901-11. PubMed ID: 5525542
    [No Abstract]   [Full Text] [Related]  

  • 19. Salivary sodium-potassium ratio and plasma renin activity in hypertension.
    Adlin V; Channick BJ; Marks AD
    Circulation; 1969 May; 39(5):685-92. PubMed ID: 5787319
    [No Abstract]   [Full Text] [Related]  

  • 20. The diagnostic and therapeutic value of spironolactone in patients with systemic hypertension.
    Burden RP; Booth LJ; Aber GM
    Nephron; 1973; 9(3):171-88. PubMed ID: 4682245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.